文献速递心力衰竭与心肌病

全血细胞衍生炎症标志物联合NT-proBNP对慢性心衰预后的预测价值

[Predictive value of whole blood cell derived inflammatory markers in combination with NT-proBNP on the prognosis of patients with chronic heart failure].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2025-01-01

该回顾性队列研究纳入324例慢性心衰住院患者,随访24.0个月,发现SII≥739.83和PLR≥151.95是慢性心衰患者全因死亡的独立预测因素。SII、PLR联合NT-proBNP的AUC为0.850,优于各指标单独应用。

要点

  • SII≥739.83与PLR≥151.95为慢性心衰全因死亡的独立预测因素。
  • SII、PLR联合NT-proBNP的AUC为0.850,优于各指标单独应用。
  • 高水平的SII、SIRI、NLR、PLR和MLR患者生存率均低于低水平者。

核心结论

  • SII、PLR和NT-proBNP与慢性心衰患者全因死亡独立相关。
  • SII和PLR可独立预测慢性心衰患者预后,联合NT-proBNP预测价值更好。

研究设计与样本

  • 本研究为回顾性队列研究,纳入2019年1月至2022年8月南方医科大学南方医院心血管内科住院的慢性心衰患者324例,年龄(64.76±13.78)岁,男性212例(65.43%)。
  • 完成随访297例(91.67%),失访27例(8.33%),随访时间24.0(18.0,41.8)个月,分为生存组258例和死亡组66例。

主要发现

  • ROC曲线确定SII、SIRI、NLR、PLR和MLR预测全因死亡的最佳临界值分别为739.83、1.65、3.14、151.95和0.37。
  • Kaplan-Meier分析显示,SII(≥739.83)、SIRI(≥1.65)、NLR(≥3.14)、PLR(≥151.95)和MLR(≥0.37)高水平患者全因死亡发生率高于低水平患者(P均<0.001)。
  • 多因素Cox回归显示,年龄(HR=1.04,95%CI 1.01~1.06,P=0.002)、NT-proBNP(HR=2.93,95%CI 1.64~5.23,P<0.001)、SII≥739.83(HR=3.27,95%CI 1.18~9.02,P=0.022)和PLR≥151.95(HR=2.67,95%CI 1.02~6.96,P=0.045)是慢性心衰患者全因死亡的独立预测因素。
  • ROC曲线显示,SII、PLR与NT-proBNP联合(AUC=0.850)预测慢性心衰患者预后的价值优于SII(AUC=0.779)、PLR(AUC=0.782)、NT-proBNP(AUC=0.727)和C反应蛋白(AUC=0.668)单独应用(P均<0.001)。

临床怎么用

  • 对于慢性心衰住院患者,可计算SII和PLR,当SII≥739.83或PLR≥151.95时提示全因死亡风险较高。
  • 将SII、PLR与NT-proBNP联合应用,有助于更全面地评估慢性心衰患者的预后风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the predictive value of whole blood cell derived inflammatory marker (including systemic immunoinflammatory index (SII), systemic inflammatory response index (SIRI), neutrophil count/lymphocyte count (NLR), platelet count/lymphocyte count (PLR), and monocyte count/lymphocyte count (MLR)) and in combination with N-terminal pro-B-type natriuretic peptide (NT-proBNP) on the prognosis of patients with chronic heart failure. Methods: This study was a retrospective cohort study. Patients with chronic heart failure hospitalized in the Department of Cardiovascular Medicine, Nanfang Hospital, Southern Medical University from January 2019 to August 2022 were enrolled. Patients were followed up and were divided into survival group and death group according to the follow-up results. Clinical characteristics of the two groups were compared. Receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of each whole blood cell derived inflammatory marker for predicting all-cause death in patients with chronic heart failure. Kaplan-Meier survival curve was drawn, and log-rank test was used to compare the difference in survival of chronic heart failure patients with different levels of whole blood cell derived inflammatory markers. Univariate and multivariate Cox proportional hazards models were used to analyze the effects of whole blood cell derived inflammatory markers and NT-proBNP on the all-cause death of patients with chronic heart failure. ROC curve was used to analyze the predictive value of whole blood cell derived inflammatory markers combined with NT-proBNP on the prognosis of patients with chronic heart failure. Results: A total of 324 patients with heart failure aged (64.76±13.78) years were enrolled, with 212 males (65.43%). 297 patients (91.67%) completed follow-up, 27 patients (8.33%) were lost to follow-up. The follow-up time was 24.0 (18.0, 41.8) months. There were 258 patients in the survival group and 66 patients in the death group. The optimal cut-off values of SII, SIRI, NLR, PLR and MLR determined by ROC curve were 739.83, 1.65, 3.14, 151.95 and 0.37, respectively. Kaplan-Meier survival curve analysis showed that patients with chronic heart failure with high levels of SII (≥739.83), SIRI (≥1.65), NLR (≥3.14), PLR (≥151.95) and MLR (≥0.37) had higher incidence of all-cause death than patients with low levels of inflammatory markers (all P<0.001). Multivariate Cox proportional hazard regression analysis showed that age (HR=1.04, 95%CI 1.01-1.06, P=0.002), NT-proBNP (HR=2.93, 95%CI 1.64-5.23, P<0.001), SII≥739.83 (HR=3.27, 95%CI 1.18-9.02, P=0.022) and PLR≥151.95 (HR=2.67, 95%CI 1.02-6.96, P=0.045) were independent predictors of all-cause death in patients with chronic heart failure. ROC curve analysis showed that the predictive value of SII and PLR combined with NT-proBNP (AUC=0.850) for the prognosis of patients with chronic heart failure was better than that of SII (AUC=0.779)、PLR (AUC=0.782)、NT-proBNP (AUC=0.727) and CRP (AUC=0.668) alone (all P<0.001). Conclusions: Whole blood cell derived inflammatory markers--SII, PLR, and NT-pro BNP were independently associated with all-cause death in patients with chronic heart failure. SII and PLR can independently predict the prognosis of patients with chronic heart failure, combination of SII and PLR with NT-pro BNP has better predictive value for the prognosis of patients with chronic heart failure. 目的: 探讨全血细胞衍生的炎症标志物[包括全身免疫炎症指数(SII)、系统炎症反应指数(SIRI)、中性粒细胞计数/淋巴细胞计数比率(NLR)、血小板计数/淋巴细胞计数比率(PLR)和单核细胞计数/淋巴细胞计数比率(MLR)]及其联合N末端B型利钠肽原(NT-proBNP)对慢性心力衰竭患者预后的预测价值。 方法: 本研究为回顾性队列研究。选取2019年1月至2022年8月在南方医科大学南方医院心血管内科住院的慢性心力衰竭患者。对患者进行随访,并根据随访情况将患者分为生存组与死亡组,比较两组患者临床特征。采用受试者工作特征(ROC)曲线确定全血细胞衍生的炎症标志物预测慢性心力衰竭患者全因死亡的最佳临界值,并绘制Kaplan-Meier生存曲线,采用log-rank法比较不同全血细胞衍生的炎症标志物水平的慢性心力衰竭患者的生存率差异。采用单因素及多因素Cox比例风险模型,分析全血细胞衍生的炎症标志物和NT-proBNP对慢性心力衰竭患者全因死亡的影响。采用ROC曲线,分析全血细胞衍生的炎症标志物及其联合NT-proBNP对慢性心力衰竭患者预后的预测价值。 结果: 共纳入324例慢性心力衰竭患者,年龄(64.76±13.78)岁,男性212例(65.43%)。完成随访297例(91.67%),失访27例(8.33%),随访时间为 24.0(18.0,41.8)个月。生存组258例,死亡组66例。通过ROC曲线确定的SII、SIRI、NLR、PLR和MLR的最佳临界值分别为739.83、1.65、3.14、151.95、0.37。Kaplan-Meier生存曲线分析显示,SII(≥739.83)、SIRI(≥1.65)、NLR(≥3.14)、PLR(≥151.95)和MLR(≥0.37)高炎症标志物水平的慢性心力衰竭患者的生存率低于低炎症标志物水平患者(P均<0.001)。多因素Cox比例风险回归分析显示,年龄(HR=1.04,95%CI 1.01~1.06,P=0.002)、NT-proBNP(HR=2.93,95%CI 1.64~5.23,P<0.001)、SII≥739.83(HR=3.27,95%CI 1.18~9.02,P=0.022)和PLR≥151.95(HR=2.67,95%CI 1.02~6.96,P=0.045)是慢性心力衰竭患者全因死亡的独立预测因素。ROC曲线显示,SII、PLR与NT-proBNP联合[曲线下面积(AUC)=0.850]对慢性心力衰竭患者预后的预测价值优于SII(AUC=0.779)、PLR(AUC=0.782)、NT-proBNP(AUC=0.727)和C反应蛋白(AUC=0.668)单独应用(P均<0.001)。 结论: 全血细胞衍生的炎症标志物——SII、PLR,以及NT-proBNP与慢性心力衰竭患者全因死亡独立相关。SII和PLR可以独立预测慢性心力衰竭患者的预后,SII、PLR与NT-pro BNP联合应用对慢性心力衰竭患者预后有较好的预测价值。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lin, Teng, Xu, et al. [Predictive value of whole blood cell derived inflammatory markers in combination with NT-proBNP on the prognosis of patients with chronic heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 39965849. doi:10.3760/cma.j.cn112148-20241211-00774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。